المؤلفون: González-Martín, Antonio, Desauw, Christophe, Heitz, Florian, Cropet, Claire, Gargiulo, Piera, Berger, Regina, Ochi, Hiroyuki, Vergote, Ignace, Colombo, Nicoletta, Mirza, Mansoor R, Tazi, Youssef, Canzler, Ulrich, Zamagni, Claudio, Guerra-Alia, Eva M, Levaché, Charles B, Marmé, Frederik, Bazan, Fernando, de Gregorio, Nikolaus, Dohollou, Nadine, Fasching, Peter A, Scambia, Giovanni, Rubio-Pérez, María J, Milenkova, Tsveta, Costan, Cristina, Pautier, Patricia, Ray-Coquard, Isabelle, PAOLA1/ENGOT-ov25 investigators

المساهمون: Gonzalez-Martin, A, Desauw, C, Heitz, F, Cropet, C, Gargiulo, P, Berger, R, Ochi, H, Vergote, I, Colombo, N, Mirza, M, Tazi, Y, Canzler, U, Zamagni, C, Guerra-Alia, E, Levache, C, Marme, F, Bazan, F, de Gregorio, N, Dohollou, N, Fasching, P, Scambia, G, Rubio-Perez, M, Milenkova, T, Costan, C, Pautier, P, Ray-Coquard, I

المصدر: European Journal of Cancer. 174:221-231

مصطلحات موضوعية: Ovarian Neoplasms, Cancer Research, Science & Technology, Antineoplastic Agents, Carcinoma, Ovarian Epithelial, Poly(ADP-ribose) Polymerase Inhibitors, Piperazines, Progression-Free Survival, Bevacizumab, Settore MED/40 - GINECOLOGIA E OSTETRICIA, PARP inhibitor, Olaparib, Antiangiogenic agent, Second progression-free survival, Double-Blind Method, Oncology, Ovarian cancer, Antineoplastic Combined Chemotherapy Protocols, Humans, Phthalazines, Female, Life Sciences & Biomedicine

وصف الملف: Print-Electronic; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a90070c60406da3d38c290af463b4e85Test
https://doi.org/10.1016/j.ejca.2022.07.022Test

المؤلفون: Mirza, Mansoor R, Chase, Dana M, Slomovitz, Brian M, dePont Christensen, René, Novák, Zoltán, Black, Destin, Gilbert, Lucy, Sharma, Sudarshan, Valabrega, Giorgio, Landrum, Lisa M, Hanker, Lars C, Stuckey, Ashley, Boere, Ingrid, Gold, Michael A, Auranen, Annika, Pothuri, Bhavana, Cibula, David, McCourt, Carolyn, Raspagliesi, Francesco, Shahin, Mark S, Gill, Sarah E, Monk, Bradley J, Buscema, Joseph, Herzog, Thomas J, Copeland, Larry J, Tian, Min, He, Zangdong, Stevens, Shadi, Zografos, Eleftherios, Coleman, Robert L, Powell, Matthew A

المساهمون: Medical Oncology

المصدر: The New England journal of medicine, 388(23), 2145-2158. Massachussetts Medical Society

مصطلحات موضوعية: Dostarlimab, Primary Advanced, Endometrial Cancer, SDG 3 - Good Health and Well-being, Primary Advanced, Dostarlimab, General Medicine, Endometrial Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1b4120439beb7d9cb61411d494af1c6Test
https://hdl.handle.net/2318/1898296Test

المؤلفون: Future Science Group, Figshare, Gonzalez-Martın, Antonio, Matulonis, Ursula A, Korach, Jacob, Mirza, Mansoor R, Moore, Kathleen N, Wu, Xiaohua, York, Whitney, Gupta, Divya, Lechpammer, Stanislav, Monk, Bradley J

مصطلحات موضوعية: Cancer therapy (excl. chemotherapy and radiation therapy)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be1e0acae828ab6e92647052069bdcb5Test

المؤلفون: Harter, Philipp, Sehouli, Jalid, Vergote, Ignace, Ferron, Gwenael, Reuss, Alexander, Meier, Werner, Greggi, Stefano, Mosgard, Berit J, Selle, Frederic, Guyon, Frédéric, Pomel, Christophe, Lécuru, Fabrice, Zang, Rongyu, Avall-Lundqvist, Elisabeth, Kim, Jae-Weon, Ponce, Jordi, Raspagliesi, Francesco, Kristensen, Gunnar, Classe, Jean-Marc, Hillemanns, Peter, Jensen, Pernille, Hasenburg, Annette, Ghaem-Maghami, Sadaf, Mirza, Mansoor R, Lund, Bente, Reinthaller, Alexander, Santaballa, Ana, Olaitan, Adeola, Hilpert, Felix, du Bois, Andreas, S Buchholz, A Burges, U Canzler, D Denschlag, A El-Balat, G Emons, R Felberbaum, N de Gregorio, M Gropp-Meier, V Hanf, L Hanker, R Hils, C Kurzeder, B Lampe, A Mustea, M Schmidt, R Schutz, M Weigel, S Weiser, A Zorr, C Marth, E Petru, T Scholl, M Beltran, I Bover, A Gomez di Laino, N Lainez, S Martinez, A Poveda Velasco, M Romeo, H Crouet, E de Gournay, G Deplanque, P Follana, A Floquet, D Lanvin, J Leveque, E Pujade-Lauraine, N Raban, B Resch, A M Savoye, G Aletti, G Giorda, F Landoni, C Scaffa, J Abu, F Alexander-Sefre, D Barton, S Butler-Manuel, R Clayton, R Crawford, T Duncan, A El-Ghobashy, C Fotopoulou, M Hall, C Intrivici, A Lawrence, D Luesley, R Naik, A Nordin, J Tidy, L Fokdahl, A Hofsjö, P Kjolhede, B Eyjolfsdottir, Z Y Dai, P Zhang, B Aminossadati, M Hahmann, C Nasemann, S Yahiaoui, M Wittenberg, C Schade-Brittinger, G Elser, D Reddig, M Kuncke, S Polleis, Y Mattukat, A Riha, R Berger, J de Roover, B Kaur, J Crook, F Nepote, B Votan, M Andriamamonjy, J Bryce, S Ristinge

المساهمون: Philipp, H, Jalid, S, Ignace, V, Gwenael, F, Alexander, R, Werner, M, Stefano, G, Berit J, M, Frederic, S, Frédéric, G, Christophe, P, Fabrice, L, Rongyu, Z, Elisabeth, A, Jae-Weon, K, Jordi, P, Francesco, R, Gunnar, K, Jean-Marc, C, Peter, H, Pernille, J, Annette, H, Sadaf, G, Mansoor R, M, Bente, L, Ana, S, Adeola, O, Felix, H, Andreas, D, Buchholz, S, Burges, A, Canzler, U, Denschlag, D, El-Balat, A, Emons, G, Felberbaum, R, de Gregorio, N, Gropp-Meier, M, Hanf, V, Hanker, L, Hils, R, Kurzeder, C, Lampe, B, Mustea, A, Schmidt, M, Schutz, R, Weigel, M, Weiser, S, Zorr, A, Marth, C, Petru, E, Scholl, T, Beltran, M, Bover, I, Gomez di Laino, A, Lainez, N, Martinez, S, Poveda Velasco, A, Romeo, M, Crouet, H, de Gournay, E, Deplanque, G, Follana, P, Floquet, A, Lanvin, D, Leveque, J, Pujade-Lauraine, E, Raban, N, Resch, B, M Savoye, A, Aletti, G, Giorda, G, Landoni, F, Scaffa, C, Abu, J, Alexander-Sefre, F, Barton, D, Butler-Manuel, S, Clayton, R, Crawford, R, Duncan, T, El-Ghobashy, A, Fotopoulou, C, Hall, M, Intrivici, C, Lawrence, A, Luesley, D, Naik, R, Nordin, A, Tidy, J, Fokdahl, L, Hofsjö, A, Kjolhede, P, Eyjolfsdottir, B, Y Dai, Z, Zhang, P, Aminossadati, B, Hahmann, M, Nasemann, C, Yahiaoui, S, Wittenberg, M, Schade-Brittinger, C, Elser, G, Reddig, D, Kuncke, M, Polleis, S, Mattukat, Y, Riha, A, Berger, R, de Roover, J, Kaur, B, Crook, J, Nepote, F, Votan, B, Andriamamonjy, M, Bryce, J, Ristinge, S

المصدر: Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J-W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J-M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F, du Bois, A & DESKTOP III Investigators 2021, ' Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer ', The New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294Test
NEW ENGLAND JOURNAL OF MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F & Du Bois, A 2021, ' Randomized trial of cytoreductive surgery for relapsed ovarian cancer ', New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294Test

مصطلحات موضوعية: EPITHELIAL OVARIAN, Oncology, medicine.medical_specialty, BEVACIZUMAB, MULTICENTER, Antineoplastic Agents, PACLITAXEL, Systemic therapy, law.invention, Antineoplastic Agent, Randomized controlled trial, law, Internal medicine, Humans, Medicine, RECURRENT, Proportional Hazards Models, Aged, Ovarian Neoplasms, SECONDARY CYTOREDUCTION, business.industry, Ovarian Neoplasm, Antineoplastic Agents/therapeutic use, Obstetrics and Gynecology, Ovarian Neoplasms/drug therapy, Cytoreduction Surgical Procedures, General Medicine, CHEMOTHERAPY, Middle Aged, OPEN-LABEL, medicine.disease, Survival Analysis, Combined Modality Therapy, Neoplasm Recurrence, Local/drug therapy, Recurrent Ovarian Cancer, Proportional Hazards Model, Quality of Life, Female, Survival Analysi, Neoplasm Recurrence, Local, business, Cytoreductive surgery, Ovarian cancer, Human

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f31361614653d123d3ce643aeba6c3Test
https://vbn.aau.dk/da/publications/7ebaa8eb-4c70-44c3-82d4-fe478c1c7475Test

المؤلفون: Ray-Coquard, Isabelle, Cibula, David, Mirza, Mansoor R, Reuss, Alexander, Ricci, Caterina, Colombo, Nicoletta, Koch, Horst, Goffin, Frédéric, González-Martin, Antonio, Ottevanger, Petronella B, Baumann, Klaus, Bjørge, Line, Lesoin, Anne, Burges, Alexander, Rosenberg, Per, Gropp-Meier, Martina, Harrela, Maija, Harter, Philipp, Frenel, Jean-Sébastien, Minarik, Tomas, Pisano, Carmela, Hasenburg, Annette, Merger, Michael, Bois, Du, Andreas, Ferrandina, Ferrandina, Maria Gabriella, AGO Study Group-led GCIG/ENGOT Intergroup Consortium

المساهمون: Ray-Coquard, I, Cibula, D, Mirza, M, Reuss, A, Ricci, C, Colombo, N, Koch, H, Goffin, F, González-Martin, A, Ottevanger, P, Baumann, K, Bjørge, L, Lesoin, A, Burges, A, Rosenberg, P, Gropp-Meier, M, Harrela, M, Harter, P, Frenel, J, Minarik, T, Pisano, C, Hasenburg, A, Merger, M, du Bois, A

المصدر: International Journal of Cancer, 146, 439-448
International Journal of Cancer, 146, 2, pp. 439-448

مصطلحات موضوعية: Cancer Research, Indoles, medicine.medical_treatment, Gastroenterology, Carboplatin, Placebos, chemistry.chemical_compound, tyrosine kinase inhibitor, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, nintedanib, Clinical endpoint, anti-angiogenic, Aged, 80 and over, Ovarian Neoplasms, Hazard ratio, Area under the curve, Cytoreduction Surgical Procedures, Middle Aged, Progression-Free Survival, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], ovarian cancer, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Nintedanib, Adult, medicine.medical_specialty, Paclitaxel, overall survival, Placebo, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Chemotherapy, business.industry, Ovary, antiangiogenic, medicine.disease, Settore MED/40 - GINECOLOGIA E OSTETRICIA, chemistry, Ovarian cancer, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afbe82c8fcc0844484fb77841f7b7b32Test
https://hdl.handle.net/2066/218867Test

المؤلفون: Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Madry, Radoslaw, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A, Lund, Bente, Malander, Susanne, Woie, Kathrine, Hellman, Kristina, Nøttrup, Trine Juhler, Havsteen, Hanne, Sehouli, Jalid, Harter, Philipp, Canzler, Ulrich, Lück, Hans-Joachim, Wölber, Linn, Marmé, Frederik, Meier, Werner, Heubner, Martin, Hilpert, Felix, Emons, Günter, Burges, Alexander, Bover Barcelo, Isabel Maria, Gil Martín, Marta, Palacio Vázquez, Isabel, Casado Herráez, Antonio, Maria del Campo, José, Lesoin, Anne, Berton-Rigaud, Dominique, N'Guyen, Thierry, Hardy-Bessard, Anne-Claire, Banerjee, Susana, Lord, Rosemary, Waters, Justin, Montes, Ana, Chan, Stephen, Williams, Sarah J, Barlow, Claire, Mullard, Anna, Colombo, Nicoletta, Scambia, Giovanni, Tognon, Germana, Scollo, Paolo, Kridelka, Frédéric, Leroy, Chantal, Debruyne, Philip, Huizing, Manon, Rosengarten, Ora, Levy, Talia, Frommer, Ronnie Shapira, Fishman, Ami, Edelman, David, Safra, Tamar, Amit, Amnon, Pikiel, Joanna, Suzin, Jacek, Mackowiak-Matejczyk, Beata, Reinthaller, Alexander, Petru, Edgar, Csoszi, Tibor, Bessette, Paul, Provencher, Diane, Lau, Susie, Ellard, Susan, Ghatage, Prafull, Moore, Kathleen, Wenham, Robert, Pineda, Mario, Azodi, Masoud, Mantia-Smaldone, Gina, Cloven, Noelle, Bailey, Cheryl, Lee, Christine, Secord, Angeles, Patel, Manish, Method, Michael, Callahan, Michael, Veena, John, Chan, John, Zarwan, Corrine, DiSilvestro, Paul, Teneriello, Michael, Gupta, Divya, Geller, Melissa, Burris, Howard, Slomovitz, Brian, Hendrickson, Andrea Wahner, McCormick, Colleen, Hanjani, Parviz, Blank, Stephanie, Haluska, Paul, Matei, Daniela, Vasilev, Stephen, Neidhart, Jeffrey, Boente, Matthew, Tchabo, Nana, Miller, David

المساهمون: Targeted Gynaecologic Oncology (TARGON)

المصدر: Mirza, M R, Monk, B J, Herrstedt, J, Oza, A M, Mahner, S, Redondo, A, Fabbro, M, Ledermann, J A, Lorusso, D, Vergote, I, Ben-Baruch, N E, Marth, C, Mądry, R, Christensen, R D, Berek, J S, Dørum, A, Tinker, A V, du Bois, A, González-Martín, A, Follana, P, Benigno, B, Rosenberg, P, Gilbert, L, Rimel, B J, Buscema, J, Balser, J P, Agarwal, S, Matulonis, U A & ENGOT-OV16/NOVA Investigators 2016, ' Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer ', The New England Journal of Medicine, vol. 375, no. 22, pp. 2154-2164 . https://doi.org/10.1056/NEJMoa1611310Test
New England Journal of Medicine, 375(22), 2154-2164. MASSACHUSETTS MEDICAL SOC

مصطلحات موضوعية: 0301 basic medicine, Oncology, Medizin, Genes, BRCA1, Platinum Compounds, POLY(ADP-RIBOSE) POLYMERASE, Kaplan-Meier Estimate, 030226 pharmacology & pharmacy, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Maintenance therapy, Bone Marrow, Medicine, Merck Sharp & Dohme, Homologous Recombination, Indazoles/adverse effects, Ovarian Neoplasms, Aged, 80 and over, Platinum compounds, OLAPARIB, Ovarian Neoplasms/drug therapy, Obstetrics and Gynecology, Bone Marrow/drug effects, General Medicine, Middle Aged, SOLID TUMORS, BRCA MUTATION CARRIERS, 030220 oncology & carcinogenesis, TRIAL, Female, Platinum sensitive, Adult, Piperidines/adverse effects, medicine.medical_specialty, Indazoles, Adolescent, Antineoplastic Agents, Disease-Free Survival, Olaparib, Maintenance Chemotherapy, Young Adult, 03 medical and health sciences, Platinum Compounds/therapeutic use, Double-Blind Method, Internal medicine, Humans, Rucaparib, Germ-Line Mutation, Aged, Neoplasm Staging, Cancer och onkologi, business.industry, Antineoplastic Agents/adverse effects, NEGATIVE BREAST-CANCER, 030104 developmental biology, chemistry, Recurrent Ovarian Cancer, Cancer and Oncology, Johnson Johnson, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef1ddf8af7801e36d2502918a7877cfTest
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-133383Test

المؤلفون: Bergmann, Troels K, Andersen, Charlotte Brasch, Gréen, Henrik, Mirza, Mansoor R, Skougaard, Kristin, Wihl, Jessica, Keldsen, Nina, Damkier, Per, Peterson, Curt, Vach, Werner, Brøsen, Kim

المصدر: Bergmann, T K, Andersen, C B, Gréen, H, Mirza, M R, Skougaard, K, Wihl, J, Keldsen, N, Damkier, P, Peterson, C, Vach, W & Brøsen, K 2012, ' Impact of ABCB1 Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer ', Basic & Clinical Pharmacology & Toxicology, vol. 110, no. 2, pp. 199-204 . https://doi.org/10.1111/j.1742-7843.2011.00802.xTest

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3062::f8eeca85d65eab970f65a0275a3bd660Test
https://portal.findresearcher.sdu.dk/da/publications/f2afe5b0-674d-4c6c-9698-70ddaa89fe60Test